Tag

The medical cannabis treatment study shows positive results in more than 80% of participants with only minor side-effects.

Khiron Life Sciences this week announced that it has received manufacturing quotas from the Colombian TQG that authorize the company to manufacture high-THC whole plant extract for both export and domestic purposes.

Khiron Life Sciences Corp. ( (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), has announced that its wholly-owned clinic network, the Latin American Institute of Neurology and the Nervous System (“ILANS”), has partnered with Colombian health insurance company...